50 MEGAVAR (Oxandrolone) by Meditech is a pharmaceutical-grade oral anabolic-androgenic steroid formulated at 50 mg per tablet — representing a high-potency oxandrolone presentation at five times the concentration of standard 10 mg oxandrolone tablets — supplied in sachets or blister packs of 100 tablets. Oxandrolone is a DHT-derived 17α-alkylated anabolic-androgenic compound with an extensive clinical and pharmacological research history, distinguished within the oral anabolic steroid class by its notably mild androgenic profile, absence of aromatization, and documented tolerability across diverse research subject populations including both male and female subjects across multiple established clinical indications.
 
✔ Key Research Insights
Studied for its DHT-derived pharmacological profile at the 50 mg dose level, including its documented absence of aromatization to estrogen, mild androgenic potency relative to anabolic activity, and absence of fluid retention in comparative anabolic-androgenic steroid research
Investigated for its effects on lean mass development and protein synthesis parameters in research subjects, with documented lean mass accrual without estrogenic water retention referenced in comparative oral anabolic steroid literature across higher dose research protocols
Researched for its influence on strength indices and endurance parameters in documented subject populations, with strength gains documented as disproportionately pronounced relative to mass accrual in comparative anabolic research observations — a characteristic consistent across oxandrolone dose ranges in research literature
Examined for its effects on fat metabolism parameters and body composition indices in caloric deficit and recomposition research protocols, with documented lean mass preservation and fat substrate utilization referenced in comparative anabolic steroid research
Documented for its 17α-alkylated oral bioavailability, with hepatotoxic considerations referenced as clinically relevant in research protocols, with dose-dependent hepatic considerations of increased relevance at the 50 mg dose level relative to lower oxandrolone dose presentations in comparative clinical literature
Researched for its recovery marker influence and inter-session training adaptation parameters in documented subject populations across anabolic pharmacology research protocols
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: 50 MEGAVAR
Molecule: Oxandrolone
Concentration: 50 mg per tablet
Appearance: White octagon-shaped tablet imprinted with logo "M"
Packing: 100 tablets per sachet or 100 tablets per blister pack
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Oxandrolone is a 17α-alkylated DHT-derived anabolic-androgenic steroid administered orally. The 17α-alkylation modification confers resistance to hepatic first-pass metabolism, enabling consistent oral bioavailability and predictable systemic availability following gastrointestinal absorption in research subjects. This structural modification is concurrently associated with hepatotoxic potential documented in clinical literature as a relevant consideration in oral anabolic steroid research protocols, with dose-dependent hepatic considerations of increased clinical relevance at the elevated 50 mg per tablet dose level referenced in comparative oxandrolone research literature. Oxandrolone exerts its primary anabolic effects through androgen receptor binding in muscle tissue, with documented downstream influences on protein synthesis and nitrogen retention in research literature. Its DHT-derived structure confers complete resistance to aromatization via the aromatase enzyme, resulting in the documented absence of estrogenic effects including fluid retention across research subject populations — a pharmacological characteristic maintaining relevance across all oxandrolone dose presentations including higher dose protocols. Unlike testosterone and nandrolone-based compounds, oxandrolone does not undergo conversion to more potent androgens in target tissues, contributing to its documented mild androgenic profile and comparatively reduced suppression of the hypothalamic-pituitary-testicular axis, though dose-dependent suppressive effects documented in research literature become an increasingly relevant clinical consideration at higher dose ranges. The 50 mg per tablet concentration provides a high-potency presentation supporting research protocols examining oxandrolone pharmacology at elevated dose parameters, with the established clinical and pharmacological profile of the oxandrolone compound documented consistently across dose ranges in comparative anabolic steroid research literature.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
High-potency 50 mg per tablet oxandrolone formulation — five times the concentration of standard presentations — supporting elevated dose research protocols with precise and consistent per-tablet dosing
DHT-derived compound with a well-documented absence of aromatization, mild androgenic profile, and absence of estrogenic fluid retention referenced consistently across comparative anabolic-androgenic steroid pharmacology research at all dose levels
Distinctively identified white octagon tablet presentation at 50 mg per tablet for consistent high-potency product recognition
Available in both sachet and blister pack formats providing 100 tablets per unit
Widely referenced in anabolic pharmacology, endocrinological, and clinical medicine research literature under the oxandrolone and Anavar designations